ClariVest Asset Management LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 3.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,018
-13.0%
87,0970.0%0.06%
-6.8%
Q2 2023$1,170
-1.0%
87,097
+22.1%
0.06%
+11.3%
Q1 2023$1,182
-11.0%
71,327
-0.1%
0.05%
-17.2%
Q4 2022$1,328
-99.9%
71,400
-1.4%
0.06%
+42.2%
Q3 2022$929,000
+83.2%
72,4000.0%0.04%
+104.5%
Q2 2022$507,000
-15.6%
72,4000.0%0.02%
-8.3%
Q1 2022$601,000
-5.2%
72,400
-47.3%
0.02%
+9.1%
Q1 2021$634,000
+46.1%
137,400
+5.9%
0.02%
+46.7%
Q4 2020$434,000
+11.0%
129,800
-1.4%
0.02%
+15.4%
Q3 2020$391,000
-39.4%
131,600
-5.7%
0.01%
-27.8%
Q2 2020$645,000
+13.4%
139,600
-5.5%
0.02%
+5.9%
Q1 2020$569,000
-3.2%
147,700
-5.9%
0.02%
+30.8%
Q4 2019$588,000
-30.2%
157,000
-1.1%
0.01%
-31.6%
Q3 2019$843,000
+38.2%
158,7000.0%0.02%
+35.7%
Q2 2019$610,000158,7000.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders